Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia

Katja Mauerer, David Zahrieh, Gullu Gorgun, Aihong Li, Jianbiao Zhou, Sascha Ansén, Laura Z. Rassenti, John G. Gribben

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The mutational status of the variable region of the immunoglobulin heavy chain gene (IgVH) is an important prognostic marker in B-cell chronic lymphocytic leukaemia (B-CLL), with mutated patients having improved outcome. To examine the impact of mutational status on VH, DH, and JH gene segment location and immunogenicity, we analysed 375 IgH sequences from 356 patients with B-CLL. Although VH and DH gene usage was different in mutated compared to unmutated patients, there was no impact of gene location on frequency of use or clinical outcome. Surprisingly, somatic mutations did not increase the immunogenicity of the Ig, as assessed by predicted binding affinity of Ig-derived peptides to major histocompatibility Class I and Class II molecules. Even excluding patients using VH1-69, cases using the VH1 gene family had a poor outcome. Both mutated and unmutated CLL patients demonstrated evidence of antigen selection. The worst outcome was seen in the subset of 14 unmutated patients with similar HCDR3 amino acid sequence using VH1-69, D H3-3 and JH6, suggesting an antigen-driven process modulating the clinical course.

Original languageEnglish (US)
Pages (from-to)499-510
Number of pages12
JournalBritish Journal of Haematology
Volume129
Issue number4
DOIs
StatePublished - May 1 2005
Externally publishedYes

Fingerprint

Immunoglobulin Genes
B-Cell Chronic Lymphocytic Leukemia
Genes
Immunoglobulin Heavy Chain Genes
Antigens
Histocompatibility
Amino Acid Sequence
Peptides
Mutation

Keywords

  • Antigen selection
  • Chronic lymphocytic leukaemia
  • HCDR3
  • MHC binding affinity
  • VDJ gene usage

ASJC Scopus subject areas

  • Hematology

Cite this

Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia. / Mauerer, Katja; Zahrieh, David; Gorgun, Gullu; Li, Aihong; Zhou, Jianbiao; Ansén, Sascha; Rassenti, Laura Z.; Gribben, John G.

In: British Journal of Haematology, Vol. 129, No. 4, 01.05.2005, p. 499-510.

Research output: Contribution to journalArticle

Mauerer, Katja ; Zahrieh, David ; Gorgun, Gullu ; Li, Aihong ; Zhou, Jianbiao ; Ansén, Sascha ; Rassenti, Laura Z. ; Gribben, John G. / Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia. In: British Journal of Haematology. 2005 ; Vol. 129, No. 4. pp. 499-510.
@article{a990291e89d346959690fd2ae60fd904,
title = "Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia",
abstract = "The mutational status of the variable region of the immunoglobulin heavy chain gene (IgVH) is an important prognostic marker in B-cell chronic lymphocytic leukaemia (B-CLL), with mutated patients having improved outcome. To examine the impact of mutational status on VH, DH, and JH gene segment location and immunogenicity, we analysed 375 IgH sequences from 356 patients with B-CLL. Although VH and DH gene usage was different in mutated compared to unmutated patients, there was no impact of gene location on frequency of use or clinical outcome. Surprisingly, somatic mutations did not increase the immunogenicity of the Ig, as assessed by predicted binding affinity of Ig-derived peptides to major histocompatibility Class I and Class II molecules. Even excluding patients using VH1-69, cases using the VH1 gene family had a poor outcome. Both mutated and unmutated CLL patients demonstrated evidence of antigen selection. The worst outcome was seen in the subset of 14 unmutated patients with similar HCDR3 amino acid sequence using VH1-69, D H3-3 and JH6, suggesting an antigen-driven process modulating the clinical course.",
keywords = "Antigen selection, Chronic lymphocytic leukaemia, HCDR3, MHC binding affinity, VDJ gene usage",
author = "Katja Mauerer and David Zahrieh and Gullu Gorgun and Aihong Li and Jianbiao Zhou and Sascha Ans{\'e}n and Rassenti, {Laura Z.} and Gribben, {John G.}",
year = "2005",
month = "5",
day = "1",
doi = "10.1111/j.1365-2141.2005.05480.x",
language = "English (US)",
volume = "129",
pages = "499--510",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia

AU - Mauerer, Katja

AU - Zahrieh, David

AU - Gorgun, Gullu

AU - Li, Aihong

AU - Zhou, Jianbiao

AU - Ansén, Sascha

AU - Rassenti, Laura Z.

AU - Gribben, John G.

PY - 2005/5/1

Y1 - 2005/5/1

N2 - The mutational status of the variable region of the immunoglobulin heavy chain gene (IgVH) is an important prognostic marker in B-cell chronic lymphocytic leukaemia (B-CLL), with mutated patients having improved outcome. To examine the impact of mutational status on VH, DH, and JH gene segment location and immunogenicity, we analysed 375 IgH sequences from 356 patients with B-CLL. Although VH and DH gene usage was different in mutated compared to unmutated patients, there was no impact of gene location on frequency of use or clinical outcome. Surprisingly, somatic mutations did not increase the immunogenicity of the Ig, as assessed by predicted binding affinity of Ig-derived peptides to major histocompatibility Class I and Class II molecules. Even excluding patients using VH1-69, cases using the VH1 gene family had a poor outcome. Both mutated and unmutated CLL patients demonstrated evidence of antigen selection. The worst outcome was seen in the subset of 14 unmutated patients with similar HCDR3 amino acid sequence using VH1-69, D H3-3 and JH6, suggesting an antigen-driven process modulating the clinical course.

AB - The mutational status of the variable region of the immunoglobulin heavy chain gene (IgVH) is an important prognostic marker in B-cell chronic lymphocytic leukaemia (B-CLL), with mutated patients having improved outcome. To examine the impact of mutational status on VH, DH, and JH gene segment location and immunogenicity, we analysed 375 IgH sequences from 356 patients with B-CLL. Although VH and DH gene usage was different in mutated compared to unmutated patients, there was no impact of gene location on frequency of use or clinical outcome. Surprisingly, somatic mutations did not increase the immunogenicity of the Ig, as assessed by predicted binding affinity of Ig-derived peptides to major histocompatibility Class I and Class II molecules. Even excluding patients using VH1-69, cases using the VH1 gene family had a poor outcome. Both mutated and unmutated CLL patients demonstrated evidence of antigen selection. The worst outcome was seen in the subset of 14 unmutated patients with similar HCDR3 amino acid sequence using VH1-69, D H3-3 and JH6, suggesting an antigen-driven process modulating the clinical course.

KW - Antigen selection

KW - Chronic lymphocytic leukaemia

KW - HCDR3

KW - MHC binding affinity

KW - VDJ gene usage

UR - http://www.scopus.com/inward/record.url?scp=20044378516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044378516&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2005.05480.x

DO - 10.1111/j.1365-2141.2005.05480.x

M3 - Article

C2 - 15877732

AN - SCOPUS:20044378516

VL - 129

SP - 499

EP - 510

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -